Filing Details
- Accession Number:
- 0001209191-11-020389
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-31 21:30:49
- Reporting Period:
- 2011-03-31
- Filing Date:
- 2011-03-31
- Accepted Time:
- 2011-03-31 21:30:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1292162 | Bryant Steven Porter | 3280 Bayshore Boulevard Brisbane CA 94005 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-03-31 | 21,179 | $42.69 | 78,908 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-03-31 | 21,179 | $47.04 | 57,729 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2011-03-31 | 21,179 | $0.00 | 21,179 | $42.69 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-08-02 | No | 4 | M | Direct |
Footnotes
- These transactions were made pursuant to a 10b5-1 trading plan entered into in the fourth quarter of 2010 and in effect at the time of the transactions. The transactions were pre-determined in the trading plan to occur at specific dates and share prices of InterMune.
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $47 to $47.16 per share. Full information on the numbers of shares sold at each sale price is available upon request.
- Fully exercisable.